II. Pathophysiology
- 
                          Lymphoproliferative Malignancy- Proliferation of plasma cells and Lymphocytes
 
- Similar to Multiple Myeloma
- Produces a large monoclonal IgM Protein
III. Epidemiology
- Older men more frequently affected
- Hereditary component
IV. Symptoms
- Weakness
- Fatigue
- Oronasal bleeding
- Blurred Vision or Decreased Visual Acuity (33%)
- No Bone pain- Contrast with Multiple Myeloma
 
- Hyperviscosity results in neurologic symptoms
- Sudden Deafness
- Progressive spinal muscular atrophy
V. Signs
- Pallor
- Splenomegaly
- Hepatomegaly
- Peripheral Lymphadenopathy
- 
                          Retinal lesions- Retinal Hemorrhage
- Retinal Exudate
- Venous congestion
 
- Peripheral Neuropathy
- Pulmonary Disease- Infiltrates or Pleural Effusion
 
VI. Labs
- 
                          Complete Blood Count
                          - Normocytic normochromic Anemia
 
- 
                          Peripheral Smear
                          - Rouleau formation
 
- Erythrocyte Sedimentation Rate markedly elevated
- 
                          Bone Marrow Biopsy
                          - Hypocellular
- Extensive Infiltrations by lymphoid and plasma cells
- Increased Mast Cell numbers
 
- 
                          Immunoelectrophoresis
                          - Monoclonal IgM Protein >3 g/dl
 
VII. Differential Diagnosis
VIII. Management
- Suppression of Lymphocyte and Plasma Cell proliferation- Chlorambucil
- Cyclophosphamide
- Combination chemotherapeutic regimens
 
- Hyperviscosity- Plasmapheresis with cell separator
 
IX. Prognosis
- Five Year median survival after diagnosis
